Effects of Ground-based Walking Training in Pulmonary Hypertension

Pulmonary Hypertension Clinical Trial

Official title:

A Randomized Controlled Trial of Ground-based Walking Training for Adult Patients With Pulmonary Hypertension

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03762577
• Other study ID #: 30146
• Status: Completed
• Phase: N/A
• Start date: December 10, 2018
• Est. completion date: March 4, 2020

Study information

• Verified date: March 2020
• Source: Istanbul University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Pulmonary Hypertension (PH) is a hemodynamic and physiopathological condition that is defined as an increase in pulmonary artery pressure ≥25 mmHg when measured at resting with symptoms such as dyspnea, fatigue, chest pain, and syncope. PH characterized by decreased exercise capacity, quality of life, peripheral muscle strength, balance, and physical inactivity. It is recommended that patients with PH should be included in cardiopulmonary rehabilitation programs in addition to medical treatment. Ground-based walking training is a safe and effective method for COPD patients. In the literature, there are no studies evaluating the effects of ground-based walking training in PH patients.

Description:

The aim of this project is to determine the effect of ground-based walking training on physical activity, exercise capacity, balance, peripheral muscle strength and quality of life in patients with PH.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 24
• Est. completion date: March 4, 2020
• Est. primary completion date: March 4, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• 18-80 years

• Diagnosed with PH

• Followed by the department of chest diseases at least six months

• Not participating in the rehabilitation program in last year

Exclusion Criteria:

• Functional group four due to WHO functional classification

• PH due to left heart diseases, PH due to lung diseases and/or hypoxia

• Treatment and medication change in the last three months

• Cooperation problems

• Patients with successful pulmonary endarterectomy operation

• Smoking

• Patients with uncontrolled cardiovascular diseases

• Patients with orthopeadic and/or neurologic disorders that could limit exercise tests

• Syncope history in recent

Related Conditions & MeSH terms

• Hypertension
• Hypertension, Pulmonary
• Pulmonary Hypertension

Intervention

Other:
• Ground-based walking training
Patients will attend a 2-day 30-minute ground-based walking training under the supervision of a physiotherapist. Patients will walk for 1-2 days in a week without supervision. According to the Modified Borg Scale, the dyspnea intensity will be 3-4 (medium to slightly difficult) and the heart rate will be completed to not exceed 120 min / pulse. Heart rate of patients will be followed by finger type pulse oximeter

Locations

Country	Name	City	State
Turkey	Ozge Ertan	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Istanbul University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Endurance exercise capacity	endurance shuttle walk test	8 weeks